Sign inJoin waitlistJoin the waitlist

Monica Gandhi

Associate Program Director - Research · University of California (San Francisco) School of Medicine

Credentials: · · · ·

History

Research · University of California (San Francisco) School of Medicine
Present
ZSFG · University of California (San Francisco) School of Medicine
Present
University of California (San Francisco) School of Medicine
Present

University of California-San Francisco
1997–1999
Harvard Medical School
1992–1996
University of California-San Francisco
1993–1996

Research

Sex differences in pharmacokinetics and pharmacodynamics
Review · The Annual Review of Pharmacology and Toxicology · 2004 · First of 4 authors · Corresponding · 416 citations
Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study
American Journal of Public Health · 2006 · 205 citations
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms
Cell Reports · 2021 · 201 citations

Matthew Spinelli
81 papers · 9 as a fellow
Diane Havlir
48 papers
Matthew Hickey
25 papers
Katerina Christopoulos
23 papers
Steven Deeks
21 papers
Susan Buchbinder
21 papers
Catherine Koss
19 papers · 2 as a fellow
Elizabeth Imbert
18 papers
Elvin Geng
17 papers
MC
Mardge Cohen
17 papers
Michael Peluso
16 papers · 12 as a fellow
Robert Grant
16 papers

Grants

Strategies to Predict Success on Long-Acting Therapy in Real-World Settings for HIV (SPLASH)
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $772.3K · University of California, San Francisco
2026–2031
University of California, San Francisco/Kaiser Permanente Northern California Division of Research Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) K12 Program
National Institute of Arthritis and Musculoskeletal and Skin Diseases · K12
PI · $2M · University of California, San Francisco
2000–2030
Triaging Dolutegravir Resistance via a Point-of-Care Urine Tenofovir Assay
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $1.4M · University of California, San Francisco
2025–2030
Randomized Trial to Optimize Virologic Suppression Rates Using a Point-of-Care Urine Monitoring Assay (ROVING-PUMA)
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $5.6M · University of California, San Francisco
2018–2028

Clinical trials

Randomized Trial to Optimize Virologic Suppression Rates Using a Point-of-Care Urine Monitoring Assay (ROVING PUMA)
Principal investigator · Recruiting
University of California, San Francisco
2025–2026
Urine Tenofovir Point-of-care Test to Identify Patients in Need of ART Adherence Support (UTRA Study)
Principal investigator · Completed
University of California, San Francisco
2022–2025
Contingency Management for PrEP Adherence and/or Methamphetamine Use
Principal investigator · Completed
University of California, Los Angeles
2021
Point-of-care Urine Monitoring of Adherence: Testing a Real-Time Urine Assay of Tenofovir in PrEP
Principal investigator · Completed
University of California, San Francisco
2021–2024